Skip to main content
SpringerLink
Log in

Cytokine Blockade in Rheumatoid Arthritis

  • Chapter
Mechanisms of Lymphocyte Activation and Immune Regulation VIII

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 490))

Abstract

As we enter the 2000’s it is clear that cytokine blockade is an effective therapeutic strategy for rheumatoid arthritis. In this brief review, we will review the rationale for anti TNFa therapy, the current status of therapy and focus on the regulation of TNFa production in rheumatoid synovium. New approaches to studying TNF regulation in RA and of elucidating the controversial role of T cells in this complex disease will be described.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. ArendW. P.and Dayer, J. M. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum33, 305–315 (1990).

    Article  PubMed  CAS  Google Scholar 

  2. Roux-Lombard, P., Modoux, C., Vischer, T., Grassi, J. and Dayer, J. M. Inhibitors of interleukin 1 activity in synovial fluids and in cultured synovial fluid mononuclear cells.J Rheumatol19, 517–523 (1992).

    PubMed  CAS  Google Scholar 

  3. Koch, A. E.et al.Synovial tissue macrophage as a source of the chemotactic cytokine IL-8.J Immunol147, 2187–2195 (1991).

    PubMed  CAS  Google Scholar 

  4. Cush, J.J. et al.Elevated interleukin-10 levels in patients with rheumatoid arthritis.Arthritis Rheum38, 96–104 (1995).

    Article  PubMed  CAS  Google Scholar 

  5. Di Giovine, F. S., Nuki, G. and Duff, G. W. Tumour necrosis factor in synovial exudates.Ann Rheum Dis47, 768–772 (1988).

    Article  PubMed  CAS  Google Scholar 

  6. Hopkins, S. J., Humphreys, M. and Jayson, M. I. Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive IL-1.Clin Exp Immunol72, 422–427 (1988).

    PubMed  CAS  Google Scholar 

  7. Feldmann, M., Brennan, F. M. and Maini, R. N. Role of cytokines in rheumatoid arthritis.Annu Rev. Immunol.14, 397–440 (1996).

    Article  PubMed  CAS  Google Scholar 

  8. Buchan, G., Barrett, K., Turner, M., Chantry, D., Maini, R. N. and Feldmann, M. Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-la.Clin Exp Immunol73, 449–455 (1988).

    PubMed  CAS  Google Scholar 

  9. Brennan, F. M., Chantry, D., Jackson, A., Maini, R. and Feldmann, M. Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-I production in rheumatoid arthritis.Lancet2, 244–7 (1989).

    Article  PubMed  CAS  Google Scholar 

  10. Brennan, F. M., Maini, R. N. and Feldmann, M. TNFaα—a pivotal role in rheumatoid arthritis?Br J Rheumatol31, 293–298 (1992).

    Article  PubMed  CAS  Google Scholar 

  11. Feldmann, M.et al.Cytokine production in the rheumatoid joint: implications for treatment.Ann Rheum Dis49, 480–486 (1990).

    PubMed  Google Scholar 

  12. Chu, C. Q., Field, M., Feldmann, M. and Maini, R. N. Localization of tumor necrosis factor a in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis.Arthritis Rheum34, 1125–1132 (1991).

    Article  PubMed  CAS  Google Scholar 

  13. Deleuran, B. W., Chu, C.Q., Field, M., Brennan, F.M., Mitchell, T., Feldmann, M. and Maini, R.N. Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha.Arthritis Rheum35, 1170–1178 (1992).

    Article  PubMed  CAS  Google Scholar 

  14. Williams, R. O., Feldmann, M. and Maini, R. N. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.Proc Natl Acad Sci USA89, 9784–9788 (1992).

    Article  PubMed  CAS  Google Scholar 

  15. Thorbecke, G. J., Shah, R., Leu, C. H., Kuruvilla, A. P., Hardison, A. M. and Palladino, M. A. Involvement of endogenous tumour necrosis factor a and transforming growth factor ß during induction of collagen type II arthritis in mice.Proc Natl Acad Sci USA89, 7375–7379 (1992).

    Article  PubMed  CAS  Google Scholar 

  16. Elliott, M. J., Maini, R.N., Feldmann, M., Long-Fox, A., Charles, P., Katsikis, P., Brennan, R.M., Walker, J., Bijl, H., Ghrayeb, J. and Woody, J. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.Arthritis Rheum36, 1681–90 (1993).

    Article  PubMed  CAS  Google Scholar 

  17. Elliott, M. J., Maini, R.N., Feldmann, M., Kalden, J.R., Antoni, C., Smolen, J.S., Leeb, B., Breedveld, F.C., Macfarlane, J.D., Bijl, H. and Woody, J.N. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.Lancet344, 1105–10 (1994).

    Article  PubMed  CAS  Google Scholar 

  18. Maini, R.N., Breedveld, F.C., Kalden, J.R., Smolen, J.S., Davis, D., Macfarlane, J.D., Antoni, C., Leeb, B., Elliott, M.J., Woody, J.N., Schaible, T.F. and Feldmann, M. Randomized placebo-controlled trial of multiple intravenous infusions of anti-TNFa monoclonal antibody with or without weekly methotrexate in rheumatoid arthritis.Arthritis Rheum.41, 1552–1563 (1998).

    Article  PubMed  CAS  Google Scholar 

  19. Maini, R. N., William, St., Clair, E., Breedveld, F., Furst, D., Kalden, J., Weisman, M., Smolen, J., Emery, P., Harriman, G., Feldmann, M., Lipsky, P. Randomised phase III trial of infliximab (chimeric anti-TNFa monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate.Lancet354, 1932–1940.

    Article  Google Scholar 

  20. Rankin, E. C., Choy, E.H.S., Kassimos, D., Soowith, M., Kingsley, G., Isenberg, D.A. and Panayi, G.S. A double blind, placebo-controlled, ascending dose trial of the recombinant humanised anti-TNFa antibody CDP571 in patients with rheumatoid arthritis (RA): A preliminary report.Arthritis Rheum37, S295 (1994).

    Google Scholar 

  21. Moreland, L.W., Baumgartner, S.W., Schiff, M.H., Tindall, E.A., Fleischmann, R.M., Weaver, A.L., Ettlinger, R.E., Cohen, S., Koopman, W.J., Mohler, K., Widmer, M.B. and Blosch, C.M. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)Fc fusion protein.New England Journal of Medicine337, 141–147 (1997).

    Article  PubMed  CAS  Google Scholar 

  22. Huang, S., Endo, R. I. and Nemerow, G. R. Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery.J Virol69, 2257–2263 (1995).

    PubMed  CAS  Google Scholar 

  23. Haddada, H., Lopez, M., Martinache, C., Ragot, T., Abina, M. A. and Perricaudet, M. Efficient adenovirus-mediated gene transfer into human blood monocyte derived macrophages.Biochem Biophys Res Commun195, 1174–1183 (1993).

    Article  CAS  Google Scholar 

  24. Foxwell, B. M. J. Brown, K., Bondeson, J., Clarke, C. de Martin, R., Brennan, F.M. and Feldmann, M.. Efficient adenoviral infection with IxBa reveals that TNFa production in rheumatoid arthritis is NF-x13 dependent.Proc Natl Acad Sci USA95, 8211–8215 (1998).

    Google Scholar 

  25. Bondeson, J., Brown, K. A., Brennan, F. M., Foxwell, B. M. J. and Feldmann, M. Selective regulation of cytokine induction by adenoviral gene transfer of IxBa into human macrophages: LPS-induced but not zymosan induced, pro-inflammatory cytokines are inhibited, but IL-10 is NF-xb independent.Jlmmunol162, 2939–2945 (1999).

    CAS  Google Scholar 

  26. Hayes, A. L., Smith, C., Foxwell, B. M. and Brennan, F. M. CD45-induced tumor necrosis factor alpha production in monocytes is phosphatidylinositol 3-kinasedependent and nuclear factor-kappa B- independent.JBiol Chem274, 33455–61 (1999)

    Article  CAS  Google Scholar 

  27. Amer, E. C., Pratta, M.A., Decicco, C.P., Xue, C.B., Newton, R.C., Trzaskos, J.M., Magolda, R.L. and Tororella, M.D. Aggrecanase. A target for the design of inhibitors of cartilage degradation.Ann NY Acad Sci878, 92–107 (1999).

    Article  Google Scholar 

  28. Bondeson, J., Foxwell, B., Brennan, F. and Feldmann, M. Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators.Proc Natl Acad Sci USA96, 5668–73 (1999).

    Article  PubMed  CAS  Google Scholar 

  29. Zandi, E., Rothwarf, D. M., Delhase, M., Hayakawa, M. and Karin, M. The IxB kinase complex (IKK) contains two kinase subunits, IKKa and IKKß, necessary for IKB phosphorylation and NF-KB activation.Cell91, 243–252 (1997).

    Article  PubMed  CAS  Google Scholar 

  30. Regnier, C. H., Song, H.-Y., Gao, X., Goeddel, D. V., Cao, Z. and Rothe, M. Identification and characterization of an IxB kinase.Cell90, 373–383 (1997).

    Article  PubMed  CAS  Google Scholar 

  31. Wallach, D., Varfolomeev, E. E., Malinin, N. L., Goltsev, Y. V., Kovalenko..A.V and Boldin, M. P. Tumor necrosis factor receptor and Fas signaling mechanisms.Annu Rev Immunol17, 331–367 (1999).

    Article  PubMed  CAS  Google Scholar 

  32. Makarov, S. S., Johnston, W.N., Olsen, J.C., Watson, J.M., Mondal, K., Rinehart, C. and Haskill, J.S. NF-xB as a target for anti-inflammatory gene therapy: suppression of inflammatory responses in monocytic and stromal cells by stable gene transfer of IKBa cDNA.Gene Therapy4, 846–852 (1997).

    Article  PubMed  CAS  Google Scholar 

  33. Falta, M. T. and Kotzin, B. L. in T Cells in Arthritis (eds Miossec, P., van den Berg, W. B. and Firestein, G. S.) 201–231 (Birkhauser Verlag, Basel, 1998).

    Book  Google Scholar 

  34. Firestein, G. S. and Zvaifler, N. J. How important are T cells in chronic rheumatoid synovitis?Arthritis Rheum33, 768–773 (1990).

    Article  PubMed  CAS  Google Scholar 

  35. Miossec, P., van den Berg, W. B. and Firestein, G. S. in Progress in Inflammation Research (ed Farnham, M. J.) 236 (Birkhauser, Basel, 1998).

    Google Scholar 

  36. Tugwell, P., Bombardier, C., Gent, M., Bennett, K.J., Bensen, W.G. Klinkhoff, A.V., Kraag, G.R., Ludwin, D. and Roberts, R.S. Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis.Lancet335, 1051–1055 (1990).

    Article  PubMed  CAS  Google Scholar 

  37. Isler, P., Vey, E., Zhang, J. H. and Dayer, J. M. Cell surface glycoproteins expressed on activated human T cells induce production of interleukin-1 beta by monocytic cells: a possible role of CD69.Eur. Cytokine Netw.4, 15–23 (1993).

    PubMed  CAS  Google Scholar 

  38. Brennan, F. M., Hayes, A. L., Ciesielski, C. J., Foxwell, B. M. J. and Feldmann, M. Cytokine activated T cells are important in TNFa synthesis in rheumatoid arthritis: P13 kinase and NF-KB pathways discriminate between cytokine and TCR activated T cells.Nature Medicinein press (2000).

    Google Scholar 

  39. Unutmaz, D., Pileri, P. and Abrignani, S. Antigen-independent activation of naïve and memory resting T cells by a cytokine combination.J Exp Med180, 1159–1164 (1994).

    Article  PubMed  CAS  Google Scholar 

  40. Sebbag, M., Parry, S. L., Brennan, F. M. and Feldmann, M. Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of TNFa but not IL-10: possible relevance to pathophysiology of rheumatoid arthritis.Eur J Immunol27, 624–632 (1997).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Kennedy Institute of Rheumatology, 1 Aspenlea Road, Hammersmith, London, W6 8LH, UK

    Marc Feldmann, Ravinder N. Maini, Jan Bondeson, Peter Taylor, Brian M. J. Foxwell & Fionula M. Brennan

Authors
  1. Marc Feldmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ravinder N. Maini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jan Bondeson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Peter Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Brian M. J. Foxwell
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Fionula M. Brennan
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of California, Irvine, Irvine, California, USA

    Sudhir Gupta

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media New York

About this chapter

Cite this chapter

Feldmann, M., Maini, R.N., Bondeson, J., Taylor, P., Foxwell, B.M.J., Brennan, F.M. (2001). Cytokine Blockade in Rheumatoid Arthritis. In: Gupta, S. (eds) Mechanisms of Lymphocyte Activation and Immune Regulation VIII. Advances in Experimental Medicine and Biology, vol 490. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1243-1_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-1243-1_13

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5458-1

  • Online ISBN: 978-1-4615-1243-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation